New Online Social Network, BioMedExperts, to Improve Collaboration Among Medical Researchers

Article of the Month!

Collexis Holdings, Inc.Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, today announced the debut of BioMedExperts - the first online social network of its kind to improve collaboration among researchers and therefore advance medical science. Collexis launched the new service with more than 1.4 million pre-generated profiles of its expected users from across 120 countries and expects to grow by another two million profiles over the next few months.

An agreement with Dell Healthcare and Life Sciences helped make BioMedExperts possible. Dell supplied the computer hardware for the service and will help market BioMedExperts.

"The ability for researchers to collaborate across scientific disciplines is becoming more and more critical," said James Coffin, Ph.D., vice president and general manager of Dell Healthcare and Life Sciences. "By connecting biologists, chemists, clinical researchers and other scientists from across the globe, BioMedExperts can play a key role in enabling a new wave of modern science and have tremendous impact on progress in biomedical research."

The new service will allow life sciences professionals to connect with each other, share data, collaborate more efficiently and conduct deep research across thousands of sources.

"Where first generation social networks like Facebook and LinkedIn require users to enter data, BioMedExperts is a life science open platform that goes to the next level – it continuously captures the research activity of experts worldwide, serving as a definitive source to identify relationships to others within the community, either by topic or geography," said Bill Kirkland, CEO of Collexis. When researchers log on to the service, which is entirely free, they will have access to approximately 12 million pre-established network connections, automatically generated from more than 6 million scientific publications from 6,500 journals. BioMedExperts encompasses almost every published researcher in the biomedical sciences field worldwide.

Searching by name, keyword or location, scientists can quickly see their own "network" of co-authors ...and even co-authors of their co-authors. The site makes it easy for researchers and scientists to analyze all associated professional connections within the network as well as find new potential research partners, co-authors, etc.

BioMedExperts includes tools that allow users to:

  • Search the network of profiles and articles by expert name or keyword and analyze the profiles of more than 1.4 million scientists by expertise, region and more
  • Customize their own profiles
  • Communicate with other members of BioMedExperts – users can invite others to their own personal network and email experts from within the entire BioMedExperts community to cultivate and grow professional affiliations
  • Set up article alerts – users can receive alerts on new articles by topic or by name (for example, users can easily track articles published by co-authors

BioMedExperts is based on Collexis' proprietary Fingerprint technology, an enterprise research tool that serves as the basis of search and retrieval solutions for such leading organizations as Harvard University, Johns Hopkins, the Mayo Clinic and The National Institutes of Health.

Kirkland added that BioMedExperts is the first in a series of professional social networks that the company plans to introduce over the next couple of years that utilizes the proprietary technology.

For further information, please visit:
http://www.biomedexperts.com

Related news articles:

About Collexis Holdings, Inc.
Named a Trend-Setting product of 2007 by KMWorld, Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA), with operations in Geldermalsen, The Netherlands and Cologne, Germany. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Merck & Co.; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. For more information, please visit www.collexis.com.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...